.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Dow
Cantor Fitzgerald
Moodys
Queensland Health
Cipla
Citi
QuintilesIMS
Johnson and Johnson

Generated: December 17, 2017

DrugPatentWatch Database Preview

Patents Expiring in January 2027

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpNEVANACnepafenacSUSPENSION/DROPS;OPHTHALMIC021862-001Aug 19, 2005RXYesYes► Subscribe► SubscribeMETHOD OF TREATING OCULAR INFLAMMATION
Takeda Pharms UsaDUETACTglimepiride; pioglitazone hydrochlorideTABLET;ORAL021925-002Jul 28, 2006ABRXYesNo► Subscribe► SubscribeY
Takeda Pharms UsaDUETACTglimepiride; pioglitazone hydrochlorideTABLET;ORAL021925-001Jul 28, 2006ABRXYesYes► Subscribe► SubscribeY
Kastle Theraps LlcKYNAMROmipomersen sodiumSOLUTION;SUBCUTANEOUS203568-001Jan 29, 2013RXYesYes► Subscribe► SubscribeY
Horizon Pharma UsaPROCYSBIcysteamine bitartrateCAPSULE, DELAYED RELEASE;ORAL203389-002Apr 30, 2013RXYesYes► Subscribe► SubscribeMANAGEMENT OF NEPHROPATHIC CYSTINOSIS BY ADMINISTERING A TOTAL DAILY DOSE IN TWO DIVIDED DOSES
Horizon Pharma UsaPROCYSBIcysteamine bitartrateCAPSULE, DELAYED RELEASE;ORAL203389-002Apr 30, 2013RXYesYes► Subscribe► SubscribeMANAGEMENT OF NEPHROPATHIC CYSTINOSIS BY ADMINISTERING A TOTAL DAILY DOSE IN TWO DIVIDED DOSES
Horizon Pharma UsaPROCYSBIcysteamine bitartrateCAPSULE, DELAYED RELEASE;ORAL203389-001Apr 30, 2013RXYesNo► Subscribe► SubscribeMANAGEMENT OF NEPHROPATHIC CYSTINOSIS BY ADMINISTERING A TOTAL DAILY DOSE IN TWO DIVIDED DOSES
Horizon Pharma UsaPROCYSBIcysteamine bitartrateCAPSULE, DELAYED RELEASE;ORAL203389-001Apr 30, 2013RXYesNo► Subscribe► SubscribeMANAGEMENT OF NEPHROPATHIC CYSTINOSIS BY ADMINISTERING A TOTAL DAILY DOSE IN TWO DIVIDED DOSES
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-002Jan 4, 2012RXYesNo► Subscribe► SubscribeYTREATMENT OF PAIN
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-007Aug 30, 2012RXYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Moodys
Farmers Insurance
QuintilesIMS
Mallinckrodt
US Department of Justice
Boehringer Ingelheim
Fuji
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot